1358 — PW Medtech Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSuper Stock

Annual income statement for PW Medtech, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	HKAS	HKAS	HKAS	HKAS	HKAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	362	247	271	537	675
Cost of Revenue
Gross Profit	222	149	166	299	381
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	361	-271	-409	414	488
Operating Profit	1.67	518	681	123	187
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	85.8	627	737	158	231
Provision for Income Taxes
Net Income After Taxes	82	632	739	129	205
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	82	632	739	106	153
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	82	632	739	106	153
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.074	0.418	0.185	0.074	0.102
Dividends per Share
Special Dividends per Share